The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1 -Antitrypsin with Negligible Toxicity
Abstract
Optimal gene therapy for many disorders will require efficient transfer to cells in vivo, high-level and long-term expression, and tissue-specific regulation, all in the absence of significant toxicity or inflammatory responses. While recombinant adenoviral vectors are efficient for gene transfer to hepatocytes, their usefulness is limited by short duration of expression related, at least in part, to immune responses to viral proteins and by a low capacity for foreign DNA. A number of systems have been developed for producing adenoviral vectors devoid of all viral coding sequences. Using AdSTK109, a vector lacking all viral coding sequences and carrying the complete human α1-antitrypsin (hAAT) genomic DNA locus, we have demonstrated sustained expression for longer than 10 months in mice. Utilizing high doses of this vector for hepatic gene transfer in mice, we find that supraphysiological levels of hAAT can be achieved without hepatotoxicity. Limited data are available to assess the efficacy and toxicity of helper-dependent adenoviral vectors with all viral coding sequences deleted. Using intravenous administration of high doses of a helper-dependent vector expressing hAAT in mice, we found long-term and high-level expression with minimal hepatic toxicity. The data suggest that helper-dependent vectors have substantially less acute and chronic, nonimmune-related toxicity likely related to the elimination of leaky viral gene expression. It may be possible to administer higher doses of helper-dependent adenoviral vectors with less toxicity compared with earlier generations of vectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725
Self-citation
Cited by
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M. A., Glorioso, J. C., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,342
Viral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858
NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice
Kojima, H., Fujimiya, M., Matsumura, K., Younan, P., Imaeda, H., Maeda, M., & Chan, L. (2003) · Nature Medicine · doi:10.1038/nm867 · Cited by 448
Morral, N., O’Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12816 · Cited by 409
Self-citationSchnell, M. A., Zhang, Y., Tazelaar, J., Gao, G.-P., Yu, Q. C., Qian, R., Chen, S.-J., Varnavski, A. N., LeClair, C., Raper, S. E., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0330 · Cited by 342
Metadata
- Authors
- Morral, N., Parks, R. J., Zhou, H., Langston, C., Schiedner, G., Quinones, J., Graham, F. L., Kochanek, S., & Beaudet, A. L.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1998-12-10
- Volume
- 9
- Issue
- 18
- Pages
- 2709-2716
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2087080914
- Cited by
- 245
- References
- 1
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1 -Antitrypsin with Negligible Toxicity. https://app.cochat.ai/papers/10.1089/hum.1998.9.18-2709
- The paper
- Morral, N., Parks, R. J., Zhou, H., Langston, C., Schiedner, G., Quinones, J., Graham, F. L., Kochanek, S., & Beaudet, A. L. (1998). High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1 -Antitrypsin with Negligible Toxicity. Human Gene Therapy. https://doi.org/10.1089/hum.1998.9.18-2709
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.